March 07, 2017
Nexstim Plc Announces the Start of Patient Enrolment in the Supplementary Phase III Trial in Stroke Rehabilitation with its NBT system
Media
March 06, 2017
NEXSTIM PLC PUBLISHES 2016 ANNUAL REPORT
March 06, 2017
Targovax to present at upcoming conferences
March 01, 2017
Cerenis Therapeutics Announces Top line Results of CARAT Phase II Study – No statistical difference observed between CER-001 and placebo
March 01, 2017
Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US
February 28, 2017
NEXSTIM PLC FINANCIAL STATEMENT RELEASE 2016
February 28, 2017
Nordic Nanovector ASA – Results for Fourth Quarter and Full Year 2016
February 27, 2017
Strongbridge Biopharma plc to Present at the 37th Annual Cowen and Company Healthcare Conference and the 29th Annual ROTH Conference
February 24, 2017
Company’s CEO Acquires Shares in Oncopeptides
February 24, 2017
Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments
